Physical Capacity in Patients With Bronchiectasis Before and After Rehabilitation Program
PCBCQ
Effects of Pulmonary Rehabilitation Associated With Respiratory Therapy vs Physiotherapy in Physical Capacity, Peripheral Muscle Strength and Quality of Life in Patients With Bronchiectasis: a Randomized Controlled Trial.
1 other identifier
interventional
50
1 country
1
Brief Summary
The hypothesis of this study is that the group of patients who will carry out the rehabilitation program associated with respiratory therapy will have higher benefits in physical function, peripheral muscle strength and quality of life compared to the group that will only perform chest physiotherapy. Additionally, there will be a negative correlation between inflammatory mediators and measures of physical ability as well as the magnitude of improvement is lower after treatment in patients with higher baseline levels of inflammation. Furthermore, these patients will be reevaluated in 1 and 3 years, as a cohort, studying if exercise capacity may be a predictor of clinical and functional outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
March 7, 2012
CompletedFirst Posted
Study publicly available on registry
August 5, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedSeptember 1, 2022
August 1, 2022
6 years
March 7, 2012
August 27, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
The change in exercise capacity in patients with bronchiectasis
Exercise capacity is measured by maximal cardiopulmonary exercise test on a cycle ergometer. The protocol will be used in ramp.
Up to 36 months
Pulmonary Function
For the cohort follow up, forced expiratory volume in the first second will be primary outcome
Up to 36 months
Exacerbations and Hospitalizations per year
For the cohort follow up, the frequency of exacerbations and hospitalizations will be evaluated
Up to 36 months
Survival in months
For the cohort follow up, the survival will be evaluated in months.
Up to 36 months
Other Outcomes (1)
Peripheral muscle function is measured by
Up to 36 months
Study Arms (2)
conventional program
EXPERIMENTALThe conventional program is conducted with duration of 8 week, twice weekly. The techniques used will be: expiration with the glottis open in lateral posture (Eltgol), autogenous drainage (AD) and shaker. Each technique will last for 30 minutes.
pulmonary rehabilitation
EXPERIMENTALDuration of 8 week, twice weekly exercise program with: lower limb strength training and aerobic training per 30 minutes.
Interventions
Pulmonary rehabilitation: 8 week, twice weekly exercise program with aerobic treadmill training and lower limb strength training.
The conventional program is conducted with duration of 8 week, twice weekly. The techniques used will be: expiration with the glottis open in lateral posture (Eltgol), autogenous drainage (AD) and shaker. Each technique will last for 30 minutes.
Eligibility Criteria
You may qualify if:
- Patients with clinical and / or CT of bronchiectasis without cystic fibrosis
- Clinically stable (no change in symptoms of dyspnea, quantity and color of the secretion)
- Greater than 18 and / or oxygen dependent at home
- Medical Research Council MRC ≥ 1.
You may not qualify if:
- Smokers or smoking history\> 10 pack / years,
- Cystic fibrosis (CF)
- Chronic obstructive pulmonary disease (COPD)
- Asthma
- Pulmonary fibrosis (PF)
- Musculoskeletal limitations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Nove de Julholead
- InCor Heart Institutecollaborator
Study Sites (1)
Universidade Nove de Julho
São Paulo, 01504001, Brazil
Related Publications (1)
de Camargo AA, de Castro RAS, Vieira RP, Oliveira-Junior MC, Araujo AA, De Angelis K, Rached SZ, Athanazio RA, Stelmach R, Corso SD. Systemic Inflammation and Oxidative Stress in Adults with Bronchiectasis: Association with Clinical and Functional Features. Clinics (Sao Paulo). 2021 Apr 16;76:e2474. doi: 10.6061/clinics/2021/e2474. eCollection 2021.
PMID: 33886789DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anderson Alves de Camargo, master's
University of Nove de Julho
- PRINCIPAL INVESTIGATOR
Rejane Agnelo Silva de Castro, Student
University of Nove de Julho
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 7, 2012
First Posted
August 5, 2014
Study Start
January 1, 2012
Primary Completion
January 1, 2018
Study Completion
July 1, 2018
Last Updated
September 1, 2022
Record last verified: 2022-08